SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision is developing SPVN06, a gene-independent drug candidate to treat retinitis pigmentosa, the most common inherited retinal degeneration.

Biotechnology

SparingVision

SparingVision's headquarters in Paris, France

Stéphane Boissel

Kali Stasi

Alexis Le Chevallier

Marie Uguen

Ryan Klimczak

Mehdi Gasmi

Florence Paliargues

Rajiv Gangurde

José Alain Sahel

Jacque Duncan

Elias Arnér

Sabine Dandiguian

Paul Sieving

Laurent Arthaud

Masayo Takahashi

Botond Roska

Owen Smith

Jeanne Cunicelli

Bart Leroy

Jean Bennett

Eric Pierce

Thierry Léveillard

Pierre Chambon

Karen Wagner

Eyal Banin

Mark Pennesi

Joseph Papa

Rusty Kelley

Dominik Fischer

Description

People (8)

Stéphane Boissel

Laurent Arthaud

Sabine Dandiguian

Anne-Sophie Gautron

Florence Paliargues

Mehdi Gasmi

Camille Breuleux

Anne Celle

Jobs